Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

An epidemiological investigation to reconstruct a probable human immunodeficiency virus-1 transmission network: a case report.

Serafino S, Cella E, Montagna C, Cavallari EN, Vittozzi P, Lo Presti A, Giovanetti M, Mazzuti L, Turriziani O, Ceccarelli G, d'Ettorre G, Vullo V, Ciccozzi M.

J Med Case Rep. 2015 Nov 3;9:253. doi: 10.1186/s13256-015-0717-2.

2.

Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.

Diallo K, Zheng DP, Rottinghaus EK, Bassey O, Yang C.

AIDS Res Hum Retroviruses. 2015 May;31(5):564-75. doi: 10.1089/AID.2014.0168. Epub 2015 Feb 5.

3.

A model-based information sharing protocol for profile Hidden Markov Models used for HIV-1 recombination detection.

Bulla I, Schultz AK, Chesneau C, Mark T, Serea F.

BMC Bioinformatics. 2014 Jun 19;15:205. doi: 10.1186/1471-2105-15-205.

4.

Identification of a novel HIV-1 second-generation recombinant form (CRF01_AE/CRF07_BC) in Jilin, China.

Feng Y, Li X, Zang X, Guo Q, Sun L, He X, Xing H, Shao Y.

AIDS Res Hum Retroviruses. 2014 Aug;30(8):819-22. doi: 10.1089/AID.2014.0071. Epub 2014 Jul 16.

5.

Current Trends of HIV Recombination Worldwide.

Lau KA, Wong JJ.

Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e4. doi: 10.4081/idr.2013.s1.e4. eCollection 2013 Jun 6. Review.

6.

Viral factors in non-progression.

Wang B.

Front Immunol. 2013 Dec 24;4:355. doi: 10.3389/fimmu.2013.00355. Review.

7.

Identification of a novel HIV Type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_AE and subtypes B and C in Western Yunnan, China.

Feng Y, Wei H, Hsi J, Xing H, He X, Liao L, Ma Y, Ning C, Wang N, Takebe Y, Shao Y.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):598-602. doi: 10.1089/AID.2013.0233. Epub 2014 Jan 4.

8.

HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

Rao M, Peachman KK, Kim J, Gao G, Alving CR, Michael NL, Rao VB.

Curr HIV Res. 2013 Jul;11(5):427-38.

9.

A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.

Sethi A, Tian J, Derdeyn CA, Korber B, Gnanakaran S.

PLoS Comput Biol. 2013;9(5):e1003046. doi: 10.1371/journal.pcbi.1003046. Epub 2013 May 16.

10.

Novel multiregion hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 circulating in Portugal.

Freitas FB, Esteves A, Piedade J, Parreira R.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):318-28. doi: 10.1089/AID.2012.0025. Epub 2012 Sep 25.

11.

Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia.

Baryshev PB, Bogachev VV, Gashnikova NM.

Arch Virol. 2012 Dec;157(12):2335-41. doi: 10.1007/s00705-012-1442-4. Epub 2012 Aug 19.

12.
13.

Quantification of unintegrated HIV-1 DNA at the single cell level in vivo.

Suspène R, Meyerhans A.

PLoS One. 2012;7(5):e36246. doi: 10.1371/journal.pone.0036246. Epub 2012 May 4.

14.

CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon.

Zhao J, Tang S, Ragupathy V, Gaddam D, Wang X, Zhang P, Nyambi PN, Hewlett I.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):344-50. doi: 10.1097/QAI.0b013e318258c7e3.

15.

Biophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor.

Chong H, Yao X, Zhang C, Cai L, Cui S, Wang Y, He Y.

PLoS One. 2012;7(3):e32599. doi: 10.1371/journal.pone.0032599. Epub 2012 Mar 5.

16.

Genetic architecture of HIV-1 genes circulating in north India & their functional implications.

Neogi U, Sood V, Ronsard L, Singh J, Lata S, Ramachandran VG, Das S, Wanchu A, Banerjea AC.

Indian J Med Res. 2011 Dec;134(6):769-78. doi: 10.4103/0971-5916.92624. Review.

17.

Broad antiviral activity and crystal structure of HIV-1 fusion inhibitor sifuvirtide.

Yao X, Chong H, Zhang C, Waltersperger S, Wang M, Cui S, He Y.

J Biol Chem. 2012 Feb 24;287(9):6788-96. doi: 10.1074/jbc.M111.317883. Epub 2012 Jan 6.

18.

Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.

Melo FL, Jamal LF, Zanotto PM.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1082-8. doi: 10.1089/AID.2011.0123. Epub 2012 Apr 16.

19.

Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.

Currier JR, Robb ML, Michael NL, Marovich MA.

J Transl Med. 2011 Dec 8;9:212. doi: 10.1186/1479-5876-9-212.

20.

Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine.

Yan J, Corbitt N, Pankhong P, Shin T, Khan A, Sardesai NY, Weiner DB.

Vaccine. 2011 Sep 22;29(41):7173-81. doi: 10.1016/j.vaccine.2011.05.076. Epub 2011 Jun 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk